amphetamine has been researched along with naltrexone in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (18.75) | 18.7374 |
| 1990's | 13 (27.08) | 18.2507 |
| 2000's | 13 (27.08) | 29.6817 |
| 2010's | 12 (25.00) | 24.3611 |
| 2020's | 1 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carino, MA; Horita, A | 1 |
| Appel, JB; Hernandez, LL; Holohean, AM | 1 |
| Holtzman, SG; Jones, DN | 1 |
| Akil, H; Trujillo, KA | 1 |
| Bechara, A; van der Kooy, D | 1 |
| Bechara, A; van der Kooy, D; Zito, KA | 1 |
| Flood, JF; Morley, JE | 1 |
| Miczek, KA; Winslow, JT | 1 |
| Messing, RB; Portoghese, PS; Sparber, SB; Takemori, AE | 1 |
| Amit, Z; Blair, R; Holmes, L; Ng Cheong Ton, MJ | 1 |
| Blumberg, H; Slovak, DM | 1 |
| Goldberg, SR; Katz, JL; Schindler, CW | 1 |
| Bowen, WD; Holtzman, SG; Jones, DN; Portoghese, PS | 1 |
| Bardo, MT; Kolta, MG | 1 |
| Holtzman, SG; Justice, JB; Schad, CA | 1 |
| Luján Estrada, M; Medina Jiménez, M; Rodríguez, R | 1 |
| Balcells-Olivero, M; Vezina, P | 1 |
| Holtzman, SG; Kimmel, HL | 1 |
| Cancela, LM; Capriles, NR; Díaz-Otañez, CS | 1 |
| Bekkedal, M; Borkowski, C; Burgdorf, J; Panksepp, J; Turner, C | 1 |
| Grech, DM; Platt, DM; Rowlett, JK; Spealman, RD | 1 |
| Gray, AM; McGinty, JF; Rawls, SM; Shippenberg, TS | 1 |
| McGinty, JF; Rawls, SM | 1 |
| France, CP; Sell, SL | 1 |
| France, CP; McMahon, LR; Sell, SL | 1 |
| Franck, J; Hurd, YL; Jayaram-Lindström, N; Wennberg, P | 1 |
| France, CP; Koek, W; McMahon, LR; Sell, SL | 1 |
| Aragon, CM; Miquel, M; Pastor, R | 1 |
| Benabid, AL; Berger, F; Buggia, V; Gilbert, F; Lévesque, D; Sgambato-Faure, V | 1 |
| Ding, Z; Phillips, AG; Powell, JA; Raffa, RB; Rawls, SM; Ross, G; Stagliano, GW | 1 |
| Bosse, KE; Gnegy, ME; Jutkiewicz, EM; Traynor, JR | 1 |
| Beck, O; Franck, J; Hammarberg, A; Jayaram-Lindström, N | 1 |
| Franck, J; Häggkvist, J; Lindholm, S | 1 |
| Arakawa, H; Bekkedal, MY; Deak, T; Panksepp, J | 1 |
| Kjome, KL; Kramer, LA; Liu, S; Ma, L; Moeller, FG; Narayana, PA; Rathnayaka, N; Schmitz, JM; Steinberg, JL | 1 |
| Bristow, RE; Grahame, NJ; Heighton, ME; Oberlin, BG | 1 |
| Dean, RL; Deaver, DR; Jimenez-Gomez, C; Winger, G; Woods, JH | 1 |
| den Hollander, BR; Pattij, T; Schetters, D; Schoffelmeer, AN; van Es, IE; van Mourik, Y; Wiskerke, J | 1 |
| Brensilver, M; Heinzerling, KG; Shoptaw, S | 1 |
| Cervenka, S; Ericson, M; Franck, J; Guterstam, J; Häggkvist, J; Halldin, C; Jayaram-Lindström, N; Malmlöf, T; Nordström, AL; Saijo, T; Schilström, B | 1 |
| Negus, SS; Sakloth, F | 1 |
| Cameron, J; Harney, A; Jenner, L; Lee, NK | 1 |
| Anand, S; Chan, EW; Lam, L; Li, X; Tse, ML; Zhao, JX | 1 |
| Azar, MR; Cunningham, JI; Dean, RL; Deaver, DR; Eyerman, DJ; Koob, GF; Todtenkopf, MS | 1 |
4 review(s) available for amphetamine and naltrexone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of amphetamine-type stimulant dependence: an update.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Bupropion; Central Nervous System Stimulants; Humans; Methylphenidate; Naltrexone; Randomized Controlled Trials as Topic | 2013 |
Pharmacotherapy for amphetamine dependence: A systematic review.
Topics: Amphetamine; Amphetamine-Related Disorders; Dextroamphetamine; Humans; Medication Adherence; Methylphenidate; Modafinil; Naltrexone; Randomized Controlled Trials as Topic | 2018 |
Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials.
Topics: Amphetamine; Amphetamine-Related Disorders; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
3 trial(s) available for amphetamine and naltrexone
| Article | Year |
|---|---|
Effects of naltrexone on the subjective response to amphetamine in healthy volunteers.
Topics: Adult; Affect; Amphetamine; Analysis of Variance; Arousal; Double-Blind Method; Euphoria; Female; Humans; Least-Squares Analysis; Male; Middle Aged; Naltrexone | 2004 |
Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Secondary Prevention; Substance Abuse Detection; Substance Withdrawal Syndrome; Survival Analysis; Treatment Outcome | 2008 |
Working memory fMRI activation in cocaine-dependent subjects: association with treatment response.
Topics: Adult; Amphetamine; Analysis of Variance; Benzhydryl Compounds; Brain; Brain Mapping; Carbidopa; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Dopamine Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mathematics; Memory Disorders; Memory, Short-Term; Middle Aged; Modafinil; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Oxygen | 2010 |
41 other study(ies) available for amphetamine and naltrexone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Analeptic and antianaleptic effects of naloxone and naltrexone in rabbits.
Topics: Amphetamine; Anesthesia; Animals; Central Nervous System Stimulants; Male; Motor Activity; Naloxone; Naltrexone; Pentobarbital; Rabbits; Reflex; Thyrotropin-Releasing Hormone; Time Factors | 1978 |
Effects of opiates on the discriminative stimulus properties of dopamine agonists.
Topics: Amphetamine; Animals; Apomorphine; Discrimination, Psychological; Dopamine; Haloperidol; Male; Morphine; Naltrexone; Narcotics; Pentazocine; Rats; Time Factors | 1978 |
Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors.
Topics: Amphetamine; Analgesia; Animals; Brain; Indoles; Male; Morphinans; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta | 1992 |
Pharmacological regulation of striatal prodynorphin peptides.
Topics: Amphetamine; Animals; Corpus Striatum; Drug Interactions; Enkephalins; Haloperidol; Male; Morphine; Naltrexone; Protein Precursors; Rats; Rats, Inbred Strains; Substantia Nigra | 1990 |
The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine.
Topics: Amphetamine; Animals; Brain Stem; Conditioning, Psychological; Dose-Response Relationship, Drug; Limbic System; Male; Morphine; Naltrexone; Narcotic Antagonists; Periaqueductal Gray; Pons; Psychotropic Drugs; Quaternary Ammonium Compounds; Rats; Rats, Inbred Strains; Retention, Psychology; Tegmentum Mesencephali | 1989 |
Peripheral receptors mediate the aversive conditioning effects of morphine in the rat.
Topics: Amphetamine; Animals; Capsaicin; Chlorides; Conditioning, Classical; Injections, Intraperitoneal; Lithium; Lithium Chloride; Male; Morphine; Naltrexone; Peritoneal Cavity; Quaternary Ammonium Compounds; Rats; Rats, Inbred Strains; Receptors, Opioid; Taste | 1987 |
An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice.
Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Calcitonin; Dextroamphetamine; Drug Tolerance; Eating; Fluoxetine; Mice; Morphine; Naltrexone; Neurotransmitter Agents | 1987 |
Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys.
Topics: Aggression; Agonistic Behavior; Amphetamine; Animals; Female; Male; Mice; Motor Activity; Naltrexone; Saimiri; Social Behavior | 1988 |
Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators.
Topics: Amphetamine; Animals; Brain; Conditioning, Operant; Exploratory Behavior; Male; Morphine; Muridae; Naloxone; Naltrexone; Nitrogen Mustard Compounds; Nociceptors; Receptors, Opioid | 1982 |
Effects of chronic naltrexone on amphetamine locomotor activity.
Topics: Amphetamine; Animals; Drug Interactions; Male; Motor Activity; Naloxone; Naltrexone; Noise; Rats; Receptors, Opioid; Stress, Physiological | 1983 |
Effects of yohimbine and naltrexone in counteraction of the morphine Straub tail and the amphetamine-potentiated morphine Straub tail in mice.
Topics: Amphetamine; Animals; Male; Mice; Morphine; Naloxone; Naltrexone; Phentolamine; Tail; Yohimbine | 1982 |
Pharmacological specificity of enhanced sensitivity to naltrexone in rats.
Topics: Amphetamine; Animals; Chlordiazepoxide; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Food; Male; Naltrexone; Narcotic Antagonists; Narcotics; Phencyclidine; Rats; Reinforcement Schedule; Stereoisomerism | 1993 |
Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine.
Topics: Amphetamine; Animals; Cocaine; Dose-Response Relationship, Drug; Enkephalin, Leucine-2-Alanine; Male; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta | 1993 |
Opioid modulation of amphetamine-stimulated dopamine release and concentration in rat striatal slices.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Dihydroxyphenylalanine; Dopamine; Hydrazines; In Vitro Techniques; Male; Morphine; Naltrexone; Narcotics; Neostriatum; Rats; Rats, Sprague-Dawley | 1993 |
Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.
Topics: Amphetamine; Analysis of Variance; Animals; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Extracellular Space; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Neostriatum; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu | 1996 |
Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice.
Topics: Amphetamine; Animals; Animals, Newborn; Animals, Suckling; Dose-Response Relationship, Drug; Drug Resistance; Female; Fetus; Hyperkinesis; Locomotion; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Opioid | 1997 |
Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections.
Topics: Amphetamine; Animals; Injections, Intraperitoneal; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley | 1997 |
Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat.
Topics: Amphetamine; Animals; Cocaine; Drug Synergism; Male; Motor Activity; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 1997 |
D1 and D2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid; Restraint, Physical; Stress, Psychological; Time Factors | 1997 |
Paradoxical effects of serotonin and opioids in pemoline-induced self-injurious behavior.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Drug Synergism; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Paroxetine; Pemoline; Rats; Rats, Sprague-Dawley; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Social Behavior; Time Factors | 1999 |
Discriminative stimulus effects of morphine in squirrel monkeys: stimulants, opioids, and stimulant-opioid combinations.
Topics: Amphetamine; Analgesics, Opioid; Anesthetics, Local; Animals; Anti-Anxiety Agents; Cocaine; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Fentanyl; Male; Morphine; Naltrexone; Narcotic Antagonists; Piperazines; Receptors, Opioid; Saimiri; Selective Serotonin Reuptake Inhibitors | 1999 |
The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum.
Topics: Amphetamine; Animals; Behavior, Animal; Benzeneacetamides; Calcium; Dopamine; Glutamic Acid; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Neostriatum; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1999 |
Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study.
Topics: Amphetamine; Animals; Calcium; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Glutamic Acid; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid, delta | 2000 |
Cocaine and amphetamine attenuate the discriminative stimulus effects of naltrexone in opioid-dependent rhesus monkeys.
Topics: Amphetamine; Animals; Cocaine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2002 |
Cocaine and other indirect-acting monoamine agonists differentially attenuate a naltrexone discriminative stimulus in morphine-treated rhesus monkeys.
Topics: Amphetamine; Animals; Biogenic Monoamines; Cocaine; Discrimination Learning; Disease Models, Animal; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Interactions; Imipramine; Macaca mulatta; Morphine; Morphine Dependence; Naltrexone; Narcotics; Substance Withdrawal Syndrome | 2004 |
Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys.
Topics: Adrenergic alpha-Agonists; Amphetamine; Analgesics, Opioid; Animals; Antidepressive Agents, Tricyclic; Biogenic Monoamines; Clonidine; Cocaine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Haloperidol; Imipramine; Macaca mulatta; Male; Methadyl Acetate; Muscle Rigidity; Naltrexone; Narcotic Antagonists; Respiratory Mechanics; Salivation; Substance Withdrawal Syndrome | 2005 |
Habituation to test procedure modulates the involvement of dopamine D2- but not D1-receptors in ethanol-induced locomotor stimulation in mice.
Topics: Amphetamine; Animals; Benzazepines; beta-Endorphin; Caffeine; Environment; Ethanol; Exploratory Behavior; Habituation, Psychophysiologic; Male; Mice; Morphine; Motor Activity; Naltrexone; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2005 |
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic Agents; AIDS-Related Complex; Amphetamine; Analgesics, Non-Narcotic; Animals; Antiparkinson Agents; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dynorphins; Dyskinesia, Drug-Induced; Functional Laterality; Homer Scaffolding Proteins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oxidopamine; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation | 2005 |
The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'.
Topics: Amphetamine; Analgesics; Analysis of Variance; Animals; Behavior, Animal; Benzoxazines; Cocaine; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Interactions; Morpholines; Naltrexone; Naphthalenes; Narcotic Antagonists; Planarians; Substance Withdrawal Syndrome; Time Factors | 2008 |
The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum.
Topics: Amphetamine; Analgesics, Opioid; Analysis of Variance; Animals; Area Under Curve; Benzamides; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Male; Naltrexone; Narcotic Antagonists; Piperazines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Subcellular Fractions; Time Factors; Tritium | 2008 |
The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat.
Topics: Amphetamine; Animals; Appetitive Behavior; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Abuse, Intravenous | 2009 |
Validation of a novel social investigation task that may dissociate social motivation from exploratory activity.
Topics: Amphetamine; Animals; Circadian Rhythm; Exploratory Behavior; Female; Haloperidol; Lighting; Male; Morphine; Motivation; Naltrexone; Psychological Tests; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Social Behavior | 2009 |
Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice.
Topics: Alcohol Drinking; Alcoholism; Amphetamine; Animals; Behavior, Addictive; Choice Behavior; Female; Impulsive Behavior; Male; Memantine; Mice; Naltrexone; Reaction Time | 2010 |
Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Female; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Self Administration | 2011 |
μ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice.
Topics: Amphetamine; Analgesics, Opioid; Animals; Attention; Central Nervous System Stimulants; Choice Behavior; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Impulsive Behavior; Inhibition, Psychological; Male; Motivation; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Peptides; Rats; Rats, Wistar; Reaction Time; Receptors, Opioid, mu; Reinforcement Schedule | 2011 |
Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.
Topics: Adult; Amphetamine; Animals; Central Nervous System Stimulants; Corpus Striatum; Cross-Over Studies; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Double-Blind Method; Humans; Male; Microdialysis; Middle Aged; Naltrexone; Narcotic Antagonists; Positron-Emission Tomography; Raclopride; Randomized Controlled Trials as Topic; Rats; Rats, Wistar; Receptors, Dopamine D2; Sweden; Translational Research, Biomedical | 2017 |
Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Deep Brain Stimulation; Dose-Response Relationship, Drug; Male; Medial Forebrain Bundle; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Self Stimulation; Substance-Related Disorders | 2018 |
Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats.
Topics: Amphetamine; Animals; Cocaine; Dopamine; Ethanol; Humans; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Oxycodone; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, mu; Self Administration; Substance-Related Disorders | 2021 |